These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3075436)

  • 1. Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.
    Chanal CM; Sirot DL; Labia R; Petit A; Morand A; Sirot JL; Cluzel RA
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1660-5. PubMed ID: 3075436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae.
    Sirot D; Chanal C; Labia R; Meyran M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1989 Oct; 24(4):509-21. PubMed ID: 2693430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.
    Petit A; Sirot DL; Chanal CM; Sirot JL; Labia R; Gerbaud G; Cluzel RA
    Antimicrob Agents Chemother; 1988 May; 32(5):626-30. PubMed ID: 3293523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids.
    Chanal CM; Sirot DL; Petit A; Labia R; Morand A; Sirot JL; Cluzel RA
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1915-20. PubMed ID: 2558614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.
    Vuye A; Verschraegen G; Claeys G
    Antimicrob Agents Chemother; 1989 May; 33(5):757-61. PubMed ID: 2665644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies.
    Sirot J; Chanal C; Petit A; Sirot D; Labia R; Gerbaud G
    Rev Infect Dis; 1988; 10(4):850-9. PubMed ID: 3055177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.
    Sirot D; Sirot J; Labia R; Morand A; Courvalin P; Darfeuille-Michaud A; Perroux R; Cluzel R
    J Antimicrob Chemother; 1987 Sep; 20(3):323-34. PubMed ID: 3316146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel transferable extended-spectrum beta-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime.
    Arlet G; Rouveau M; Bengoufa D; Nicolas MH; Philippon A
    FEMS Microbiol Lett; 1991 Jun; 65(1):57-62. PubMed ID: 1874404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation of antibiotic resistance determinants including an extended-spectrum beta-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli.
    Sirot D; De Champs C; Chanal C; Labia R; Darfeuille-Michaud A; Perroux R; Sirot J
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1576-81. PubMed ID: 1929328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
    Arlet G; Rouveau M; Fournier G; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2020-3. PubMed ID: 8239625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
    Steward CD; Rasheed JK; Hubert SK; Biddle JW; Raney PM; Anderson GJ; Williams PP; Brittain KL; Oliver A; McGowan JE; Tenover FC
    J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of cefotaxime-resistant but ceftazidime-susceptible Enterobacterales and evaluation of the in vitro bactericidal activity of ceftazidime and cefepime.
    Marchisio ML; Liebrenz KI; Méndez ELA; Di Conza JA
    Braz J Microbiol; 2021 Dec; 52(4):1853-1863. PubMed ID: 34269999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.
    Papanicolaou GA; Medeiros AA; Jacoby GA
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2200-9. PubMed ID: 1963529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
    Blahová J; Hupková M; Králiková K; Krcméry V; Lísková A; Kubonová K
    Zentralbl Bakteriol; 1998 Jul; 288(1):75-86. PubMed ID: 9728407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri.
    Yang Y; Bhachech N; Bradford PA; Jett BD; Sahm DF; Bush K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1671-6. PubMed ID: 9661002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.